skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Intraoperative Ir-192 implantation for early breast cancer. Techniques and results

Journal Article · · Cancer (Philadelphia); (USA)
 [1]
  1. Thomas Jefferson Univ. Hospital, Philadelphia, PA (USA)

Patients with early breast cancer (T1-2 N0-1) can be treated by lumpectomy and irradiation with a local control and survival equal to more radical surgery. Between 1982 and 1988, 323 patients with early breast cancer were treated, when possible, with Ir-192 implants at the time of lumpectomy to a local dose of 2000 cGy in 40-50 hours. Ten to 14 days later, the whole breast was treated to 4500 cGy at 180 per fraction in 5 weeks. The 6-year actuarial survival for stages I and II disease was 98% and 91%, respectively, and the recurrence-free survival was 96% and 98%, respectively. When these 323 patients were evaluated by T status, a local control of 97% was the same for T1 and T2 lesions. The cosmetic results were good to excellent in 95% of the patients. This approach has improved our ability to accurately place the boost dose in the breast.

OSTI ID:
6717140
Journal Information:
Cancer (Philadelphia); (USA), Vol. 66:1; ISSN 0008-543X
Country of Publication:
United States
Language:
English

Similar Records

Breast conservation treatment with perioperative interstitial irradiation
Journal Article · Thu Oct 01 00:00:00 EDT 1987 · Am. J. Clin. Oncol.; (United States) · OSTI ID:6717140

Conservative management of operable breast cancer. Ten years experience at the Foundation Curie. [Gamma radiation]
Conference · Sun Oct 01 00:00:00 EDT 1978 · Cancer; (United States) · OSTI ID:6717140

Impact of radiotherapy technique on the outcome of early breast cancer treated with conservative surgery: A multicenter observational study on 1,176 patients
Journal Article · Tue Aug 01 00:00:00 EDT 2006 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:6717140